Skip to content

Drug interactions

Methylergonovine + Ziprasidone

Severity: Minor

Methylergonovine and Ziprasidone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Methylergonovine is an ergot derivative with serotonergic and vasoconstrictive activity and is metabolized by CYP3A4, and ziprasidone is a weak CYP3A4 substrate that does not meaningfully inhibit it. Serotonin syndrome or neuroleptic malignant syndrome is only a theoretical concern with short courses.

What this interaction means in plain words

Methylergonovine and Ziprasidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Theoretical pharmacodynamic overlap at serotonin and dopamine receptors; no established pharmacokinetic interaction.

What to do

Monitor for agitation, hyperthermia, rigidity and autonomic instability during the short postpartum course. No dose adjustment is normally needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Methylergonovine and Ziprasidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Methylergonovine with Ziprasidone?

MediHelp rates the interaction as minor. Methylergonovine and Ziprasidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Methylergonovine is an ergot derivative with serotonergic and vasoconstrictive activity and is metabolized by CYP3A4, and ziprasidone is a weak CYP3A4 substrate that does not meaningfully inhibit it. Serotonin syndrome or neuroleptic malignant syndrome is only a theoretical concern with short courses.

How serious is the interaction between Methylergonovine and Ziprasidone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for agitation, hyperthermia, rigidity and autonomic instability during the short postpartum course. No dose adjustment is normally needed.

What other medicines interact with Ziprasidone?

MediHelp also lists interactions of Ziprasidone with, for example, Amiodarone, Amitriptyline, Arsenic trioxide. The full list is on the Ziprasidone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in